10x Genomics, Inc. (TXG)

10x Genomics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-76.32	-182.63	-255.1	-166	-58.22	-542.73
Depreciation & Amortization	42.28	43.71	43.62	33.01	28.25	19.02
Other Amortization	-	-	-	-	-	0.02
Loss (Gain) From Sale of Assets	-	-	-	-	-	0.03
Asset Writedown & Restructuring Costs	1.41	3.05	9.85	-	-	306
Loss (Gain) From Sale of Investments	-	0	1.72	-	-	-
Stock-Based Compensation	116.44	140.75	166.95	136.85	95.96	48.63
Other Operating Activities	-0.27	0.52	0.43	1.96	0.08	1.52
Change in Accounts Receivable	40.18	26.95	-10.61	-18.95	-34.04	-17.85
Change in Inventory	31.99	-9.78	7.87	-21.19	-30.13	-14.6
Change in Accounts Payable	-10.11	-3.35	-6.02	5.86	11.08	-7.77
Change in Unearned Revenue	2.42	11.21	10.93	3.35	1.54	2.02
Change in Other Net Operating Assets	-59.49	-23.78	15.17	-8.49	-35.89	-12.19
Operating Cash Flow	88.53	6.66	-15.2	-33.61	-21.37	-217.9
Capital Expenditures	-6.87	-12.39	-48.6	-131.66	-101.28	-36.67
Cash Acquisitions	-8.62	-	-	-4	-5.45	-
Sale (Purchase) of Intangibles	-	-1	-0.92	-	-	-1.73
Investment in Securities	-47.74	-19.24	183.02	-215.23	-	-
Investing Cash Flow	-63.23	-32.63	133.49	-350.89	-106.73	-38.39
Long-Term Debt Repaid	-	-	-5.81	-5.41	-5.03	-37.1
Total Debt Repaid	-	-	-5.81	-5.41	-5.03	-37.1
Net Debt Issued (Repaid)	-	-	-5.81	-5.41	-5.03	-37.1
Issuance of Common Stock	9.08	10.91	19.48	21.23	40.33	506.01
Financing Cash Flow	9.08	10.91	13.67	15.82	35.3	468.91
Foreign Exchange Rate Adjustments	0.17	-0.16	-0.03	-0.04	0.23	-0.46
Net Cash Flow	34.55	-15.22	131.93	-368.72	-92.57	212.15
Free Cash Flow	81.65	-5.73	-63.8	-165.27	-122.65	-254.56
Free Cash Flow Margin	12.72%	-0.94%	-10.31%	-32.00%	-25.01%	-85.18%
Free Cash Flow Per Share	0.66	-0.05	-0.55	-1.45	-1.11	-2.52
Cash Interest Paid	-	-	0.44	0.84	1.22	1.67
Cash Income Tax Paid	2.71	5.64	4.93	3.93	8.66	0.28
Levered Free Cash Flow	112.06	59.82	27.63	-92.66	-67.02	-20.17
Unlevered Free Cash Flow	112.06	59.83	27.65	-92.36	-66.48	-19.14
Change in Working Capital	4.99	1.25	17.34	-39.42	-87.45	-50.38

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q